Literature DB >> 20383507

An unusual effect of colchicine treatment in familial Mediterranean fever-associated glomerulonephritis.

Mevlut Ceri, Selman Unverdi, Mustafa Altay, Rahmi Yılmaz, Murat Duranay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20383507     DOI： 10.1007/s00296-010-1498-y

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


× No keyword cloud information.
  6 in total

Review 1.  Familial Mediterranean fever.

Authors:  Fatos Onen
Journal:  Rheumatol Int       Date:  2005-11-10       Impact factor: 2.631

Review 2.  Familial Mediterranean fever and mesangial proliferative glomerulonephritis: report of a case and review of the literature.

Authors:  Deniz N Cagdas; Safak Gucer; Gülsev Kale; Ali Duzova; Seza Ozen
Journal:  Pediatr Nephrol       Date:  2005-06-22       Impact factor: 3.714

3.  A possible favorable effect of colchicine in IgA nephropathy in a carrier of a MEFV mutation.

Authors:  L Koukoui; A Blau; J Kopolovic; M Pras; A Livneh
Journal:  Clin Nephrol       Date:  2004-09       Impact factor: 0.975

Review 4.  Familial Mediterranean fever and glomerulonephritis and review of the literature.

Authors:  Tekin Akpolat; Ilkser Akpolat; Filiz Karagoz; Engin Yilmaz; Bedri Kandemir; Seza Ozen
Journal:  Rheumatol Int       Date:  2003-06-27       Impact factor: 2.631

Review 5.  Familial Mediterranean Fever: a review for clinical management.

Authors:  Claudia Fonnesu; Claudia Cerquaglia; Maria Giovinale; Valentina Curigliano; Elena Verrecchia; Giuliana de Socio; Micaela La Regina; Giovanni Gasbarrini; Raffaele Manna
Journal:  Joint Bone Spine       Date:  2008-12-16       Impact factor: 4.929

Review 6.  Familial Mediterranean fever and IgA nephropathy: case report and review of the literature.

Authors:  F Gok; E Sari; O Erdogan; D Altun; O Babacan
Journal:  Clin Nephrol       Date:  2008-07       Impact factor: 0.975
  6 in total
  1 in total

1.  Frequency of familial Mediterranean fever (MEFV) gene mutations in patients with biopsy-proven primary glomerulonephritis.

Authors:  Can Huzmeli; Ferhan Candan; Gokhan Bagci; Demet Alaygut; Ali Yilmaz; Asim Gedikli; Binnur Bagci; Meryem Timucin; Ilhan Sezgin; Mansur Kayatas
Journal:  Clin Rheumatol       Date:  2017-06-01       Impact factor: 2.980
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.